Interventional Cardiologist I Structural I # Program Director, SHD fellowship, Oregon Health & Science University, Portland
Portland, OR
Joined April 2010
- Tweets1.8K
- Following993
- Followers1.8K
- Likes3.2K
Now Accepting Applications – Structural Heart Disease Fellowship at OHSU!
>600 structural cases a year, lots of TAVRs, LAAO, Mitral/Tricuspids, PVLs, and ASD/PFO closure-
only 1 structural fellow/year!
Email: [email protected]
Interviewing for structural fellowship for academic year 2025-2026. Interested fellows are welcome to apply to OHSU. One of the leading centers in structural space with TAVR, TMVR, TTVR, LAAO and lot of cutting edge early feasibility trials- contact [email protected] with CV/LORs!
Excellent #NYValves2024...thank you for the directors and planning committee @crfheart @jgranadacrf @PradeepYadavMD @ShariqShamimMD @kashishgoelmd @ZaidAlMarzooq ..Can't wait to be at #NYValves2025 with many new updates over the year..
Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study - The Lancet thelancet.com/journals/lance…
Harsh Golwala retweeted
💟 Congrats, Harsh Golwala and Firas Zahr on your collaborative editorial ⬇️🌟
doi.org/10.1016/j.jcin.2023.…
@ACCinTouch
@HarshGMD
@SVRaoMD
@Pooh_Velagapudi
@noshreza
@HeartOTXHeartMD
@adityadoc1
@ZainAsadEP
@iamritu
@purviparwani
@renujain19
@davidmcnam
@dr_benoy_n_shah
Hospital Procedural Volume and Clinical Outcomes of Transcatheter Aortic Valve Replacement: United States Nationwide Readmission Database, 2016-2019 - Journal of the Society for Cardiovascular Angiography & Interventions jscai.org/article/S2772-9303…
Harsh Golwala retweeted
Edwards Pascal Precision Transcatheter Valve Repair System Receives FDA Approval For Degenerative Mitral Regurgitation
ir.edwards.com/news/news-det…
Harsh Golwala retweeted
Interventional cardiologist should be aware of and participate in RUC surveys. You can have a direct impact on your reimbursement. Our webinar series at the SCAI website scai.org/professional-develo… provides in-depth information on surveys and advice on member participation.
Harsh Golwala retweeted
🔥Our team rocking the stage this morning #ESC in Barcelona. Presenting analysis on #TAVR outcomes by procedural volume. We showed strong volume-mortality correlation in 260K #TAVR cases in🇺🇸
Thanks @HarshGMD for leading!
#ESCCongress #esc2022 #ESC22 #MedTwitter #CardioTwitter
Questions about LAA closure (1/2):
1. TEE underestimates sizing- are there more patients ineligible for closure related to CT vs. TEE sizing as we screen more patients with CT?
2. Sizing of elliptical LAA vs. circular LAA on CT? E.g. 30 x 18 vs. 25 x 24 mm
2/2:
3. Despite good coverage on 45-day TEE, penetration of contrast seen on 45-day CT more often- how can we understand this better to tailor DAPT vs. OAC continuation or discontinuation.
Thoughts? @MCoylewright @AGoldsweig @anvoramd @Drdevignair @DJ_Lakkireddy @drrakeshg1
Harsh Golwala retweeted
CCI Manuscript on SDM and Quality Published:
Integrating shared decision-making in coronary revascularization with quality assurance programs
Lloyd W. Klein MD, H. Vernon Anderson MD, Joaquin Cigarroa MD
First published: 29 May 2022
doi.org/10.1002/ccd.30222
Harsh Golwala retweeted
Despite higher STS score the intermediate-term mortality risk and outcomes after TAVI were comparable in patients with and without prior CABG at our center. pubmed.ncbi.nlm.nih.gov/3538…
Important work led by OHSU fellow Kris Kumar
@OHSUCardFellow
What is your anti platelet/anticoagulation strategy 6 weeks post watchman if everything looks ok @ShariqShamimMD @adnanalkhouli @MCoylewright @CJChungMD @Gupta_MD @SanonSaurabh @sanghaimd @DJ_Lakkireddy @drrakeshg1 @anvoramd @TheNarulaSeries
30%ASA 81 mg daily x12 m
0%ASA 325 mg daily x 12m
68%ASA 81/Plavix 75 mgx 6 m
2%Low dose DOAC x 6 m
40 votes • Final results Harsh Golwala retweeted
A wonderful review of the mechanisms, pharmacokinetics and key clinical trials of platelet inhibitors in STEMI by our very own 3rd year fellow Kris Kumar and interventional cardiologist @HarshGMD !
amjmed.com/article/S0002-934… – at Portland, OR